Medicare Advantage Overpayments Reach Record Highs
Congressional advisers are sounding the alarm over ballooning Medicare Advantage (MA) spending. In 2026, the federal government will pay insurance companies 14% more to cover Medicare Advantage enrollees than it would cost to cover those same people under traditional Medicare. That gap translates to a staggering $76 billion surplus flowing directly to private health insurers.
Furthermore, this figure comes from the Medicare Payment Advisory Commission — better known as MedPAC — in its newly released annual report. As an independent body that advises Congress on Medicare policy, MedPAC carries significant authority. Consequently, its findings have reignited debate over whether the government is getting fair value from its Medicare Advantage contracts.
What MedPAC’s 2026 Report Reveals
A Growing Payment Gap
MedPAC’s 2026 annual report shows a widening gap between what the government pays Medicare Advantage plans and what traditional Medicare would cost for the same beneficiaries. Specifically, the 14% overpayment rate means that for every dollar spent on comparable traditional Medicare coverage, the government spends $1.14 on Medicare Advantage.
A Pattern of Overpayments
This is not a new finding. MedPAC has consistently flagged Medicare Advantage overpayments in previous annual reports as well. Nevertheless, the dollar figure keeps climbing — and in 2026, it has reached its highest recorded level. Together, these trends point to structural issues in how the government sets MA payment rates.
Why Insurers Are Paid More Than Traditional Medicare
Several factors drive the overpayment gap. First, risk scoring practices allow insurers to report enrollees as sicker than they actually are, thereby triggering higher federal payments. This practice — known as upcoding — has been a persistent concern for federal health officials and watchdog groups alike.
In addition, benchmark payment rates in many counties remain artificially high. As a result, insurers collect excess revenue even when their actual costs are lower. Moreover, Medicare Advantage plans often attract healthier enrollees, which further inflates the apparent value they deliver compared with their actual costs.
Industry Groups Fight Back Against MedPAC
Lobbying Campaigns Target MedPAC’s Credibility
Rather than address the findings, major insurance industry lobbying groups have launched an aggressive campaign against MedPAC itself. Organizations such as the Better Medicare Alliance and the Healthcare Leadership Council — both backed by health insurers — have publicly criticized MedPAC’s methodology and promoted alternative analyses.
A Call to Defund MedPAC
These groups have gone further, endorsing a recent Wall Street Journal editorial that called for MedPAC to be defunded entirely. That editorial questioned the commission’s independence and suggested its recommendations favor traditional Medicare over private plans. Industry advocates have amplified this message across Washington, lobbying the Trump administration to increase Medicare Advantage funding rather than cut it.
Legislative Threats to MedPAC’s Independence
Beyond the media campaign, insurance-backed groups are also supporting legislation in Congress that would restrict how MedPAC staff conduct their research. If enacted, such measures could limit the commission’s ability to produce independent analyses. Analysts and policy experts warn that weakening MedPAC’s research capacity could make it harder for Congress to obtain unbiased data on Medicare spending.
This legislative push reflects a broader strategy. Instead of engaging with MedPAC’s data, insurers are working to undercut the institution producing it. Critics argue this approach prioritizes industry profits over fiscal responsibility and beneficiary welfare.
What This Means for Taxpayers and Seniors
The $76 billion overpayment figure has real consequences. That money comes from federal tax revenue — funds that could otherwise support expanded Medicare benefits, reduce premiums, or address other healthcare priorities.
Yet seniors enrolled in Medicare Advantage are not necessarily receiving $76 billion in extra care. Instead, a significant portion of these excess payments likely becomes insurer profit or administrative overhead. Meanwhile, traditional Medicare — which covers the remaining enrollees — faces ongoing budget pressures. Therefore, the payment imbalance affects all Medicare beneficiaries, not just those in private plans.
The Road Ahead for Medicare Advantage Reform
Congress Faces a Critical Choice
MedPAC’s report gives Congress clear evidence to act. Lawmakers could adjust benchmark rates, tighten upcoding rules, or increase audits of MA plan risk scores. However, the intense industry lobbying campaign makes reform politically difficult.
Will the Trump Administration Step In?
The Trump administration faces pressure from insurers to raise MA payment rates in 2026 and beyond. MedPAC’s findings directly contradict that push. How the administration responds will shape the program’s financial trajectory — and signal whether federal oversight or industry influence holds more sway over Medicare policy.
